Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,60%
1 084,99
-6,52
-0,60%
—1 091,511 090,401 090,401 081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,24%
608,66
-1,45
-0,24%
—610,11610,11610,11606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,29%
1 241,53
+3,55
+0,29%
—1 237,981 237,831 241,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,14%
1 742,22
-2,49
-0,14%
—1 744,711 740,951 746,201 735,64——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
642,27
+2,09
+0,33%
—640,18639,92642,40636,70——
SIXR
Staples
SIXR
Staples
SIXR
+0,04%
849,94
+0,36
+0,04%
—849,58845,27850,93841,28——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,10%
217,69
+0,22
+0,10%
—217,48217,48217,77216,39——
SIXT
Technology
SIXT
Technology
SIXT
+0,69%
3 283,08
+22,39
+0,69%
—3 260,693 273,363 287,813 269,07——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,31%
945,37
+2,92
+0,31%
—942,45939,39948,80934,04——
SIXV
Health care
SIXV
Health care
SIXV
-0,12%
1 465,08
-1,72
-0,12%
—1 466,801 464,701 466,471 458,68——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,10%
2 399,96
+2,46
+0,10%
—2 397,502 395,032 404,632 391,98——
Q2 2026 earnings • released • EPS miss -12,58% • Revenue beat +2,83%
See results
TWST:NASDAQ
Twist Bioscience Corp
58,15 USD
-3,73%
(-2,25) 1D
4-май, 10:39:43 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TWST...
Open
59,20 USD
High
60,95 USD
Low
56,01 USD
Mkt. cap
3,47 млд
Volume
681,63 миң
52-wk high
66,06 USD
52-wk low
23,30 USD
EPS
-1,27 USD
Beta
2,22
Shares outstanding
61,31 млн
No. of employees
979
News stories
From sources across the web
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp
CEOEmily LeProust
Employees979
Founded2013
Headquarters-
Sector-
Websitetwistbioscience.com
Last report
Just released
Today, 08:00
Fiscal Period
Q2 2026
Normalized EPS / Estimate
-0,60/ (-0,53 est.)USD
-12,58%miss
Revenue / Estimate
110,72 млн/ (107,66 млн est.)USD
+2,83%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
92,79 млн
96,06 млн
99,01 млн
103,70 млн
Cost of goods sold
46,76 млн
44,76 млн
48,17 млн
49,73 млн
Cost of revenue
46,76 млн
44,76 млн
48,17 млн
49,73 млн
Research and development expenses
23,92 млн
18,05 млн
17,01 млн
17,13 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63,67 млн
63,37 млн
63,76 млн
69,74 млн
Operating expense
87,59 млн
81,42 млн
80,77 млн
86,87 млн
Total operating expenses
134,35 млн
126,18 млн
128,94 млн
136,60 млн
Operating income
-41,56 млн
-30,12 млн
-29,93 млн
-32,90 млн
Other non operating income
-251,00 миң
-836,00 миң
420,00 миң
471,00 миң
EBT including unusual items
-39,15 млн
20,58 млн
-26,88 млн
-30,25 млн
EBT excluding unusual items
-39,15 млн
-28,27 млн
-26,88 млн
-30,25 млн
Income tax expense
175,00 миң
191,00 миң
257,00 миң
253,00 миң
Effective tax rate
-0,45%
0,93%
-0,96%
-0,84%
Other operating expenses
-
-
-
-
Net income
-39,33 млн
20,39 млн
-27,14 млн
-30,51 млн
Net profit margin
-42,38%
21,23%
-27,41%
-29,42%
Earnings per share
-0,66
-0,47
-0,45
-0,50
Interest and investment income
2,80 млн
2,69 млн
2,63 млн
2,18 млн
Interest expense
-143,00 миң
-
-
-
Net interest expenses
2,66 млн
2,69 млн
2,63 млн
2,18 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-35,16 млн
-24,06 млн
-26,83 млн
-27,01 млн
Gain or loss from assets sale
-
-48,85 млн
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer